These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1318011)

  • 1. Human immunodeficiency virus activates c-myc and Epstein-Barr virus in human B lymphocytes.
    Astrin SM; Laurence J
    Ann N Y Acad Sci; 1992 May; 651():422-32. PubMed ID: 1318011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus induction of malignant transformation in human B lymphocytes.
    Laurence J; Astrin SM
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7635-9. PubMed ID: 1652756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
    Price AM; Messinger JE; Luftig MA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.
    Polack A; Hörtnagel K; Pajic A; Christoph B; Baier B; Falk M; Mautner J; Geltinger C; Bornkamm GW; Kempkes B
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10411-6. PubMed ID: 8816814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on transforming functions of Epstein-Barr virus-specific proteins].
    Kinoshita T
    Hokkaido Igaku Zasshi; 1990 Jul; 65(4):362-75. PubMed ID: 2172130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cells.
    Pajic A; Staege MS; Dudziak D; Schuhmacher M; Spitkovsky D; Eissner G; Brielmeier M; Polack A; Bornkamm GW
    Int J Cancer; 2001 Sep; 93(6):810-6. PubMed ID: 11519042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD; Rowe M; Rickinson AB
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2 and c-Myc co-operate in the Epstein-Barr virus-immortalized human B-cell line GM607 but do not confer tumorigenicity.
    Tomlin JL; Guinn BA; Penn LZ; Berinstein NL
    Leuk Lymphoma; 2005 Apr; 46(4):581-92. PubMed ID: 16019487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immortalized Epstein-Barr virus-positive B-cell lines obtained by prolonged culture of peripheral blood mononuclear cells from human immunodeficiency virus type 1-positive patients.
    Ruibal-Ares B; Belmonte L; Baré P; Scolnik M; Palacios MF; Bayo-Hanza C; Galmarini CM; Mendez G; de Bracco MM
    J Hum Virol; 2001; 4(4):200-13. PubMed ID: 11694848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.
    Schlee M; Krug T; Gires O; Zeidler R; Hammerschmidt W; Mailhammer R; Laux G; Sauer G; Lovric J; Bornkamm GW
    J Virol; 2004 Apr; 78(8):3941-52. PubMed ID: 15047810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines.
    Zhang RD; Guan M; Park Y; Tawadros R; Yang JY; Gold B; Wu B; Henderson EE
    AIDS Res Hum Retroviruses; 1997 Jan; 13(2):161-71. PubMed ID: 9007201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 Tat protein modulates cell cycle and apoptosis in Epstein-Barr virus-immortalized B cells.
    Colombrino E; Rossi E; Ballon G; Terrin L; Indraccolo S; Chieco-Bianchi L; De Rossi A
    Exp Cell Res; 2004 May; 295(2):539-48. PubMed ID: 15093750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.
    Martorelli D; Muraro E; Mastorci K; Dal Col J; Faè DA; Furlan C; Giagulli C; Caccuri F; Rusnati M; Fiorentini S; Carbone A; Caruso A; Dolcetti R
    Int J Cancer; 2015 Sep; 137(6):1374-85. PubMed ID: 25704763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
    J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered HIV expression and EBV-induced transformation in coinfected PBLs and PBL subpopulations.
    Henderson EE; Yang JY; Zhang RD; Bealer M
    Virology; 1991 May; 182(1):186-98. PubMed ID: 1708929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-infected marmoset cells transfected with c-myc do not form lymphomas in mice with severe combined immunodeficiency.
    Salimi B; O'Gorman MR; Variakojis D; Bendet M; Newman M; Poupko E; Katz BZ
    Mol Genet Metab; 1998 Jul; 64(3):205-12. PubMed ID: 9719630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man.
    Rowe M; Young LS; Crocker J; Stokes H; Henderson S; Rickinson AB
    J Exp Med; 1991 Jan; 173(1):147-58. PubMed ID: 1845872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective Epstein-Barr Virus Genomes and Atypical Viral Gene Expression in B-Cell Lines Derived from Multiple Myeloma Patients.
    Lu F; Martin KA; Soldan SS; Kossenkov AV; Wickramasinghe P; Vladimirova O; De Leo A; Lin C; Nefedova Y; Lieberman PM
    J Virol; 2021 Jun; 95(13):e0008821. PubMed ID: 33883224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection of Epstein-Barr virus-transformed lymphoblastoid B cells by the human immunodeficiency virus: evidence for a persistent and productive infection leading to B cell phenotypic changes.
    De Rossi A; Roncella S; Calabro ML; D'Andrea E; Pasti M; Panozzo M; Mammano F; Ferrarini M; Chieco-Bianchi L
    Eur J Immunol; 1990 Sep; 20(9):2041-9. PubMed ID: 2170147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.